Welcome to our dedicated page for Catalyst Crew Technologies SEC filings (Ticker: CCTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Catalyst Crew Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Catalyst Crew Technologies's regulatory disclosures and financial reporting.
Catalyst Crew Technologies Corp. completed a transformational deal and change in control, shifting from an inactive shell to a development-stage digital health and artificial intelligence healthcare analytics company. The company acquired AI-enabled analytics and telehealth-related assets from its new CEO, Dr. Kevin Rodan Levy, in exchange for 12,000,000 restricted common shares.
Dr. Levy also purchased 28,000,000 existing shares for $10,000 in cash, giving him beneficial ownership of about 40,000,000 shares, or roughly 71.1% of the 56,296,895 common shares outstanding. All prior directors and officers resigned, and Dr. Levy became sole director and officer. The business remains pre-revenue, requires substantial additional capital, holds key patents only in Venezuela, and faces significant regulatory, competitive, and going concern risks as it tries to build and commercialize its AI and telehealth platforms, initially targeting Latin American markets.
Catalyst Crew Technologies Corp. (CCTC) filed its Q3 2025 report, showing no revenue and a smaller quarterly net loss as the company remains pre‑revenue. Net loss was $36,302 for the quarter ended September 30, 2025, improving from $43,481 a year ago. For the nine months, net loss was $89,939 versus $2,343,608 in 2024, primarily due to lower stock‑based compensation.
The balance sheet reflects constrained liquidity: cash $0, current liabilities $663,514, and a working capital deficit of $663,514. Debt includes promissory notes of $264,414, related‑party notes of $88,042, and convertible notes of $34,591. Interest expense totaled $26,183 for the nine months.
Management disclosed a going concern uncertainty due to continuing losses and lack of committed financing. Internal controls over financial reporting were deemed not effective with material weaknesses tied to limited resources and segregation of duties. Common shares outstanding were 29,276,895 as of November 14, 2025.